🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/01/2003 | 20,21 | 20,85 | 19,84 | 20,47 | +1,86% | 5,00% | 141.919 |
| 31/12/2002 | 20,03 | 21,15 | 19,91 | 20,10 | -0,74% | 6,17% | 142.694 |
| 30/12/2002 | 20,92 | 21,71 | 20,14 | 20,25 | -6,08% | 7,51% | 211.543 |
| 27/12/2002 | 22,01 | 22,46 | 21,04 | 21,56 | -3,52% | 6,46% | 76.730 |
| 26/12/2002 | 22,27 | 22,38 | 21,75 | 22,35 | +0,34% | 2,86% | 49.185 |
| 24/12/2002 | 21,93 | 22,38 | 21,90 | 22,27 | +1,02% | 2,22% | 102.619 |
| 23/12/2002 | 20,44 | 22,16 | 20,21 | 22,05 | +7,68% | 9,52% | 120.198 |
| 20/12/2002 | 20,40 | 21,30 | 19,73 | 20,47 | +4,79% | 7,71% | 110.019 |
| 19/12/2002 | 20,44 | 20,96 | 19,35 | 19,54 | -2,97% | 7,88% | 161.689 |
| 18/12/2002 | 21,11 | 21,26 | 20,03 | 20,14 | -4,78% | 5,85% | 157.762 |
| 17/12/2002 | 22,05 | 22,08 | 20,89 | 21,15 | -4,24% | 5,43% | 264.255 |
| 16/12/2002 | 22,50 | 22,53 | 21,60 | 22,08 | -1,50% | 4,16% | 151.136 |
| 13/12/2002 | 22,50 | 22,65 | 21,86 | 22,42 | +0,67% | 3,49% | 97.649 |
| 12/12/2002 | 22,46 | 23,02 | 22,08 | 22,27 | -0,83% | 4,17% | 199.119 |
| 11/12/2002 | 22,08 | 22,57 | 21,82 | 22,46 | +0,50% | 3,39% | 173.819 |
| 10/12/2002 | 22,83 | 23,36 | 21,60 | 22,35 | +0,00% | 7,70% | 237.645 |
| 09/12/2002 | 22,27 | 22,46 | 21,63 | 22,35 | +1,19% | 3,70% | 304.330 |
| 06/12/2002 | 22,01 | 22,42 | 21,26 | 22,08 | +0,85% | 5,27% | 198.505 |
| 05/12/2002 | 21,48 | 22,08 | 21,00 | 21,90 | +2,63% | 5,05% | 180.925 |
| 04/12/2002 | 21,52 | 22,12 | 21,04 | 21,34 | -2,56% | 5,04% | 318.516 |
| 03/12/2002 | 19,91 | 22,46 | 19,61 | 21,90 | +10,17% | 14,29% | 612.239 |
| 02/12/2002 | 20,14 | 20,21 | 19,46 | 19,88 | +2,31% | 3,72% | 135.106 |
| 29/11/2002 | 19,43 | 20,17 | 19,16 | 19,43 | -0,19% | 5,20% | 77.746 |
| 27/11/2002 | 19,31 | 19,88 | 19,28 | 19,46 | +0,78% | 3,10% | 230.485 |
| 26/11/2002 | 19,50 | 19,76 | 19,28 | 19,31 | -2,09% | 2,49% | 445.126 |
| 25/11/2002 | 19,50 | 19,80 | 18,94 | 19,73 | +1,54% | 4,41% | 362.438 |
| 22/11/2002 | 18,83 | 19,46 | 18,71 | 19,43 | +2,98% | 3,98% | 562.386 |
| 21/11/2002 | 19,54 | 20,03 | 18,27 | 18,86 | -1,18% | 9,00% | 1.808.879 |
| 20/11/2002 | 18,68 | 19,76 | 17,37 | 19,09 | +3,66% | 12,83% | 2.071.263 |
| 19/11/2002 | 19,73 | 20,81 | 18,38 | 18,42 | -6,29% | 12,33% | 549.936 |